KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Asset Writedowns and Impairment (2022 - 2025)

Hims & Hers Health's Asset Writedowns and Impairment history spans 4 years, with the latest figure at $531000.0 for Q3 2025.

  • For Q3 2025, Asset Writedowns and Impairment changed N/A year-over-year to $531000.0; the TTM value through Dec 2025 reached $531000.0, up 365.79%, while the annual FY2025 figure was $531000.0, 365.79% up from the prior year.
  • Asset Writedowns and Impairment for Q3 2025 was $531000.0 at Hims & Hers Health, up from $39000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $1.1 million in Q3 2022 and bottomed at $39000.0 in Q2 2024.
  • The 4-year median for Asset Writedowns and Impairment is $429000.0 (2023), against an average of $434800.0.
  • The largest YoY upside for Asset Writedowns and Impairment was 82.52% in 2024 against a maximum downside of 82.52% in 2024.
  • A 4-year view of Asset Writedowns and Impairment shows it stood at $1.1 million in 2022, then tumbled by 61.0% to $429000.0 in 2023, then tumbled by 90.91% to $39000.0 in 2024, then skyrocketed by 1261.54% to $531000.0 in 2025.
  • Per Business Quant, the three most recent readings for HIMS's Asset Writedowns and Impairment are $531000.0 (Q3 2025), $39000.0 (Q2 2024), and $75000.0 (Q1 2024).